Results 21 to 30 of about 701,063 (234)

Ganoderic Acid Production via Aerial Co-cultivation of Ganoderma lucidum with Bacillus subtilis and Aspergillus niger Using Bubble Column Bioreactor [PDF]

open access: yesApplied Food Biotechnology
Background and Objective: Ganoderma lucidum, with its medicinal characteristics, is one of the most beneficial fungi in traditional Asian medicine.
Soheil Kianirad   +6 more
doaj   +3 more sources

Ganoderic acid A ameliorates non-alcoholic streatohepatitis (NASH) induced by high-fat high-cholesterol diet in mice. [PDF]

open access: yesExp Ther Med, 2022
Non-alcoholic steatohepatitis (NASH) is becoming a huge global health problem. Previous studies have revealed that ganoderic acids have hepatoprotective and hypocholesterolemic effects.
Zhu J, Ding J, Li S, Jin J.
europepmc   +2 more sources

Ganoderic acid A attenuated hepatic impairment by down-regulating the intracellular JAK2-STAT3 signaling pathway in induced mushroom poisoning. [PDF]

open access: yesAm J Transl Res
BACKGROUND Mushroom poisoning is one of the most prominent public health problems. However, there is no special antidote so far. In the present study, we verified that Ganoderma lucidum may be an effective approach for treatment of acute mushroom ...
Xiao C, Huang G, Cao X, Li X.
europepmc   +2 more sources

Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer's Disease (Mouse Model) through Autophagy Induced by Activating Axl. [PDF]

open access: yesInt J Mol Sci, 2021
Alzheimer’s disease (AD) is thought to be caused by amyloid-β (Aβ) accumulation in the central nervous system due to deficient clearance. The aim of the present study was to investigate the effect of ganoderic acid A (GAA) on Aβ clearance in microglia ...
Qi LF, Liu S, Liu YC, Li P, Xu X.
europepmc   +2 more sources

A New Triterpenoid Glucoside from a Novel Acidic Glycosylation of Ganoderic Acid A via Recombinant Glycosyltransferase of Bacillus subtilis [PDF]

open access: yesMolecules, 2019
Ganoderic acid A (GAA) is a bioactive triterpenoid isolated from the medicinal fungus Ganoderma lucidum. Our previous study showed that the Bacillus subtilis ATCC (American type culture collection) 6633 strain could biotransform GAA into compound (1 ...
Te-Sheng Chang   +5 more
doaj   +4 more sources

A novel approach to enhancing ganoderic acid production by Ganoderma lucidum using apoptosis induction. [PDF]

open access: yesPLoS ONE, 2013
Ganoderma lucidum is one of most widely used herbal medicine and functional food in Asia, and ganoderic acids (GAs) are its active ingredients. Regulation of GA biosynthesis and enhancing GA production are critical to using G.
Bang-Jau You   +7 more
doaj   +4 more sources

A novel molecular imprinted electrochemical biosensor for sensitive determination of Ganoderic acid A

open access: yesJournal of Physics: Conference Series
Analytical approaches with the features of easy manipulation, cost-effectiveness, and miniature are needed for practice-oriented point-of-care diagnostics.
Wenwei Li, Yao Xie, Axin Liang
semanticscholar   +2 more sources

Ganoderic Acid A Alleviates OVA-Induced Asthma in Mice. [PDF]

open access: yesInflammation, 2021
AbstractThe aim of this study is to investigate the effects of ganoderic acid A (GAA) on OVA-induced asthma in mice. Mouse asthma model was established by ovalbumin (OVA) in vitro. Diff-Quik staining was used to observe the total numbers of cells and the number of classification cells in each group, and HE staining was used to observe lung inflammation
Lu X, Xu C, Yang R, Zhang G.
europepmc   +4 more sources

Multi-omics integration identifies ganoderic acid A as a TNFα inhibitor for treating sepsis-related liver injury

open access: yesFrontiers in Pharmacology
Ganoderic acid A (GAA), a major bioactive triterpenoid from Ganoderma lucidum, is known for its anti-inflammatory effects; however, its precise molecular targets in sepsis-related liver injury (SRLI) remain unclear.
Hong Hu   +9 more
doaj   +2 more sources

Ganoderic Acid A targeting leucine-rich repeat kinase 2 involved in Parkinson's disease-A computational study. [PDF]

open access: yesAging Med (Milton), 2023
AbstractObjectiveThis study aims to find the most promising Ganoderma lucidium targeting LRRK2 involved in PD.MethodsFirst ADMET analysis was performed for five compounds followed by molecular docking of each compound. Then, we perform molecular dynamics simulation of all five compounds and finally MMGBSA of all five compounds.ResultsBased on molecular
Ahmad F.
europepmc   +4 more sources

Home - About - Disclaimer - Privacy